Emilie Skrobala

  • Citations Per Year
Learn More
Cognitive impairment, especially verbal episodic memory and executive function impairments, has been considered to be a possible adverse effect of aromatase inhibitors (AI). This phase III open-label study compared the impact of tamoxifen and AI on verbal episodic memory (Rey auditory verbal learning test—RAVLT) and other cognitive functions (visual memory,(More)
BACKGROUND Determinants of early-onset Alzheimer's disease (EOAD) are not well known. In late-onset AD, vascular risk factors (VRFs) are associated with earlier clinical manifestation. OBJECTIVE The objective of this study was to assess the putative association between VRFs and EOAD. METHODS We studied participants with dementia meeting criteria for(More)
  • 1